Inventor · disambiguated record
Jan Poolman
Also filed as: POOLMAN JAN · POOLMAN JAN T · POOLMAN JAN THEUNIS
56 granted patents·79 pending applications·482 citations·filing 1987–2025
99Inventor score
Files withGLAXOSMITHKLINE BIOLOG SA32GLAXOSMITHKLINE BIOLOGICALS SA23BIEMANS RALPH LEON13JANSSEN PHARMACEUTICALS INC11SMITHKLINE BEECHAM BIOLOG6
Top patents by PatentIndex Score
135 records- 0195US9884113B2Pneumoccal polysacchride conjugate vaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Granted Feb 6, 2018·13 cites·13 claims
- 0295US8703148B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2007·Granted Apr 22, 2014·31 cites·10 claims
- 0394US9486515B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Nov 8, 2016·16 cites·7 claims
- 0494US8398983B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Mar 19, 2013·17 cites·31 claims
- 0593US10583185B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Mar 10, 2020·12 cites·20 claims
- 0693US8431136B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Apr 30, 2013·13 cites·23 claims
- 0792US11446370B2Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·6 cites·42 claims
- 0892US9789179B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Oct 17, 2017·11 cites·39 claims
- 0992US9107872B2Pneumococcal polysaccharide conjugate vaccineBIEMANS RALPH LEON·Filed 2009·Granted Aug 18, 2015·14 cites·10 claims
- 1092US8883163B2Immunogenic compositionGLAXOSMITHKLINE BIOLOG SA·Filed 2013·Granted Nov 11, 2014·11 cites·18 claims
- 1191US10646564B2VaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Granted May 12, 2020·2 cites·9 claims
- 1291US10245317B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Apr 2, 2019·5 cites·11 claims
- 1391US9358279B2Immunogenic compositionGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Granted Jun 7, 2016·8 cites·1 claims
- 1490US10279033B2Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugatesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted May 7, 2019·5 cites·1 claims
- 1590US8029807B2Outer membrane vesicles and uses thereofGLAXOSMITHKLINE BIOLOG SA·Filed 2009·Granted Oct 4, 2011·14 cites·2 claims
- 1688US10166287B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jan 1, 2019·3 cites·4 claims
- 1788US9931397B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Apr 3, 2018·6 cites·17 claims
- 1888US9610339B2Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugatesBIEMANS RALPH LEON·Filed 2008·Granted Apr 4, 2017·10 cites·16 claims
- 1988US9610340B2Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugatesBIEMANS RALPH LEON·Filed 2008·Granted Apr 4, 2017·11 cites·16 claims
- 2087US8221770B2Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidisBIEMANS RALPH·Filed 2010·Granted Jul 17, 2012·9 cites·19 claims
- 2187US7628995B2Outer membrane vesicles and uses thereofGLAXOSMITHKLINE BIOLOG SA·Filed 2004·Granted Dec 8, 2009·34 cites·8 claims
- 2286US9168313B2VaccineGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Granted Oct 27, 2015·6 cites·4 claims
- 2385US11931405B2Bioconjugates of E. coli O-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Mar 19, 2024·1 cites·22 claims
- 2485US10730917B2Fusion proteins and combination vaccines comprising haemophilus influenzae Protein E and Pilin AGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Aug 4, 2020·1 cites·5 claims
- 2585US8163295B2Outer membrane vesicles and uses thereofBOS MARTINE PETRONELLA·Filed 2011·Granted Apr 24, 2012·6 cites·2 claims
- 2685US7838014B2Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB- Neisseria meningitidisGLAXOSMITHKLINE BIOLOG SA·Filed 2003·Granted Nov 23, 2010·17 cites·6 claims
- 2783US9233151B2Vaccine compositionBOUTRIAU DOMINIQUE·Filed 2012·Granted Jan 12, 2016·10 cites·10 claims
- 2883US8945577B2Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin ABLAIS NORMAND·Filed 2012·Granted Feb 3, 2015·4 cites·6 claims
- 2983US2022354941A1Pneumococcal capsular saccharide conjugate vaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 3082US9296794B2Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin AGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Granted Mar 29, 2016·3 cites·2 claims
- 3181US10548963B2Immunogenic composition for use in vaccination against staphylococciGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Feb 4, 2020·4 cites·9 claims
- 3281US5034519AOligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccinesNEDERLANDEN STAAT·Filed 1987·Granted Jul 23, 1991·33 cites·9 claims
- 3379US7118757B1Meningococcal class 1 outer-membrane protein vaccineNEDERLANDEN STAAT·Filed 1994·Granted Oct 10, 2006·55 cites·9 claims
- 3477US12076385B2Methods and compositions for immune protection against extra-intestinal pathogenic E. coliGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Granted Sep 3, 2024·0 cites·22 claims
- 3577US9259461B2Vaccine comprising protein NMB0964 from Neisseria meningitidisBOS MARTINE PETRONELLA·Filed 2009·Granted Feb 16, 2016·4 cites·6 claims
- 3677US8679770B2Serum bactericidal assay for N. meningitidis specific antiseraDE VLEESCHAUWER ISABEL·Filed 2005·Granted Mar 25, 2014·9 cites·9 claims
- 3777US5705161AImmunogenic meningococcal LPS and other membrane vesicles and vaccine therefromNEDERLANDEN STAAT·Filed 1993·Granted Jan 6, 1998·42 cites·13 claims
- 3876US12233121B2Methods of producing bioconjugates of E. coli O-antigen polysaccharides, compositions thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Feb 25, 2025·0 cites·8 claims
- 3976US10214569B2Fusion proteins and combination vaccines comprising Haemophilus influenzae protein E and pilin AGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Feb 26, 2019·1 cites·12 claims
- 4076US10023616B2Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin AGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Jul 17, 2018·1 cites·4 claims
- 4176US9409957B2Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin AGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2014·Granted Aug 9, 2016·1 cites·2 claims
- 4276US9365624B2VaccinePOOLMAN JAN·Filed 2011·Granted Jun 14, 2016·5 cites·4 claims
- 4375US11198707B2Fusion proteins and combination vaccines comprising Haemophilus influenzae Protein E and Pilin AGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Dec 14, 2021·0 cites·15 claims
- 4475US9314518B2Treatment of streptococcal infectionsGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Granted Apr 19, 2016·2 cites·3 claims
- 4573US7811590B2Haemophilus influenzae outer membrane protein and use thereof in vaccinationUNIV OHIO STATE RES FOUND·Filed 2007·Granted Oct 12, 2010·1 cites·10 claims
- 4672US2024316172A1Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereofJANSSEN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4771US8926985B2VaccineCAPIAU CARINE·Filed 2009·Granted Jan 6, 2015·2 cites·12 claims
- 4871US2020000911A1Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Application pending·0 cites
- 4969US11400147B2Pneumococcal capsular saccharide conjugate vaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Aug 2, 2022·0 cites·12 claims
- 5069US11241495B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Feb 8, 2022·0 cites·5 claims
Showing the top 50 of 135 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →